<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01913977</url>
  </required_header>
  <id_info>
    <org_study_id>2013/386</org_study_id>
    <nct_id>NCT01913977</nct_id>
  </id_info>
  <brief_title>Clinical Study to Determine the Optimal Operation Parameters During CO2 Removal With the Abylcap® System</brief_title>
  <official_title>Clinical Study to Determine the Optimal Operation Parameters During CO2 Removal With the Abylcap® System.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Ghent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Ghent</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective study includes 5 patients with ARDS (Acute Respiratory Distress Syndrome)
      treated by mechanical ventilation. In case of respiratory acidosis, extracorporeal CO2
      (carbon dioxide)removal might be necessary. We hereby work with the Abylcap system with the
      oxygenator Lilliput2 as CO2 remover (Bellco, Italy).

      The patients (M/V) are older than 18, not pregnant, have a BMI&lt;30, and no contraindication
      for anticoagulation therapy.

      Under standard conditions patients are treated with a blood flow of QB=300mL/min and a gas
      flow (100% 02) of QG=7L/min. Blood sampling is performed from the arterial bloodline in the
      patients at 0, 1h, 3h, 24h, 48h, 72h, 96h, and 120h.

      A parameter study is also performed to optimise CO2 removal. Herewith, blood samples (1mL)
      are taken from the inlet and outlet line of the Lilliput2 at the previously mentioned time
      points and for different flow setting: Blood flow (QB) 200-300-400mL/min and gas flow (QG)
      1.5, 3, 6, 7, 8L/min

      Blood samples are analysed for the different blood gases from which the extraction in the CO2
      remover can be calculated for each setting of QB (blood flow) and QG (gas flow).
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>calculation of CO2 extraction in blood samples during mechanical ventilation</measure>
    <time_frame>during mechanical ventilation with CO2 removal (max up to 120h)</time_frame>
    <description>Extraction is calculated from the relative difference in blood gases at the inlet and outlet of the CO2 remover.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Based on the extraction rates, the optimum parameter settings are derived</measure>
    <time_frame>During mechanical ventilation with CO2 removal (max up to 120h)</time_frame>
    <description>Extraction is calculated from the relative difference in blood gases at the inlet and outlet of the CO2 remover.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">5</enrollment>
  <condition>ARDS (Acute Respiratory Distress Syndrome)</condition>
  <condition>Respiratory Acidosis</condition>
  <arm_group>
    <arm_group_label>Treatment with mechanical ventilation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Abylcap system with the oxygenator Lilliput2 as CO2 remover (Bellco, Italy).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Abylcap® System: blood flow (QB): 200mL/min; gas flow (QG):7L/min</intervention_name>
    <description>Abylcap settings</description>
    <arm_group_label>Treatment with mechanical ventilation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Abylcap® System: blood flow (QB): 300mL/min; gas flow (QG):7L/min</intervention_name>
    <description>Abylcap settings</description>
    <arm_group_label>Treatment with mechanical ventilation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Abylcap® System: blood flow (QB): 400mL/min; gas flow (QG):7L/min</intervention_name>
    <description>Abylcap settings</description>
    <arm_group_label>Treatment with mechanical ventilation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Abylcap® System: blood flow (QB): 400mL/min; gas flow (QG):1.5L/min</intervention_name>
    <description>Abylcap settings</description>
    <arm_group_label>Treatment with mechanical ventilation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Abylcap® System: blood flow (QB): 400mL/min; gas flow (QG):3L/min</intervention_name>
    <description>Abylcap settings</description>
    <arm_group_label>Treatment with mechanical ventilation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Abylcap® System: blood flow (QB): 400mL/min; gas flow (QG):6L/min</intervention_name>
    <description>Abylcap settings</description>
    <arm_group_label>Treatment with mechanical ventilation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Abylcap® System: blood flow (QB): 400mL/min; gas flow (QG):8L/min</intervention_name>
    <description>Abylcap settings</description>
    <arm_group_label>Treatment with mechanical ventilation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with ARDS and respiratory acidosis on the intensive care unit

          -  Treated with the Abylcap system (Bellco, Italy)

          -  Not pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sunny Eloot, PhD, MScBME, MScCivE</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Ghent</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sunny Eloot, PhD, Engr.</last_name>
    <phone>+32 93321025</phone>
    <email>Sunny.Eloot@ugent.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ghent University Hospital</name>
      <address>
        <city>Gent</city>
        <state>Oost-Vlaanderen</state>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sunny Eloot, PhD, MScBME, MScCivE</last_name>
      <phone>+32 9 3321025</phone>
      <email>Sunny.Eloot@ugent.be</email>
    </contact>
    <investigator>
      <last_name>Sunny Eloot, PhD, MScBME, MScCivE</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 6, 2013</study_first_submitted>
  <study_first_submitted_qc>July 31, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 1, 2013</study_first_posted>
  <last_update_submitted>June 2, 2015</last_update_submitted>
  <last_update_submitted_qc>June 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 3, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
    <mesh_term>Acidosis</mesh_term>
    <mesh_term>Acidosis, Respiratory</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

